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Studies on sugar intake and its link to cardiometabolic risk show inconsistent results,
partly due to dietary misreporting. Cost-effective and easily measured nutritional
biomarkers that can complement dietary data are warranted. Measurement of 24-h
urinary sugars is a biomarker of sugar intake, but there are knowledge gaps regarding
the use of overnight urine samples. We aim to compare (1) overnight urinary sucrose
and fructose measured with liquid chromatography-tandem mass spectrometry, (2)
self-reported sugar intake measured with web-based 4-day food records, (3) their
composite measure, and (4) these different measures’ (1–3) cross-sectional associations
with cardiometabolic risk factors in 991 adults in the Malmö Offspring Study (18–69
years, 54% women). The correlations between the reported intakes of total sugar, added
sugar and sucrose was higher for urinary sucrose than fructose, and the correlations
for the sum or urinary sucrose and fructose (U-sugars) varied between r≈0.2–0.3 (P <
0.01) in men and women. Differences in the direction of associations were observed
for some cardiometabolic risk factors between U-sugars and reported added sugar
intake, as well as between the sexes. In women, U-sugars, but not reported added
sugar intake, were positively associated with systolic and diastolic blood pressure and
fasting glucose. Both U-sugars and added sugar were positively associated with BMI
and waist circumference in women, whereas among men, U-sugars were negatively
associated with BMI and waist circumference, and no association was observed for
added sugar. The composite measure of added sugars and U-sugars was positively
associated with BMI, waist circumference and systolic blood pressure and negatively
associated with HDL cholesterol in women (P < 0.05). Conclusively, we demonstrate
statistically significant, but not very high, correlations between reported sugar intakes and
U-sugars. Results indicate that overnight urinary sugars may be used as a complement
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to self-reported dietary data when investigating associations between sugar exposure
and cardiometabolic risk. However, future studies are highly needed to validate the
overnight urinary sugars as a biomarker because its use, instead of 24-h urine, facilitates
data collection.
Keywords: added sugar intake, nutritional biomarkers, urinary sucrose and fructose, overnight urinary sugars,
cardiometabolic risk factors
INTRODUCTION
Sugars have received increasing attention in recent decades and
have been linked to metabolic syndrome and related conditions
and diseases (obesity, type 2 diabetes and cardiovascular
disease) (1–3). However, the strength of the available evidence
is weak (4), and the inconsistent results might partly be
explained by difficulties in measuring sugar intake as an
exposure. Misreporting through self-reported dietary assessment
methods is a challenge that complicates the conclusions of
epidemiological investigations of health risks associated with
high sugar consumption. Hence, there is a need to identify
objective measurements of dietary intake in the form of
nutritional biomarkers to complement subjective self-reported
data (5). It should also be emphasized that with this need
for nutritional biomarkers follows an almost equally important
need for these biomarkers to be relatively cost-effective and
easily measured.
The measurement of 24-h urinary sucrose and fructose as a
predictive biomarker for sugar intake was first recognized after its
dose-response relationship was demonstrated through controlled
sugar intake and its validity to estimate sugar intake (after
ad libitum intake) was confirmed (6). Thereon, this biomarker
has been compared against several different dietary assessment
methods (7, 8), e.g., correlation of r = 0.21 with a 4-day
food record (8). As compared to the predictive 24-h urinary
sugar biomarker, the concentration biomarker from spot or
overnight urinary sugar samples (9, 10) is substantially easier to
collect but has only been compared with reported sugar intake
in three previous studies (two in the same cohort) (11–13).
Only one of these studies, which was performed in children,
reported correlation coefficients between the spot morning
urinary sugar levels and reported sugar intake (r = 0.25) (13).
In the other cohort, higher urinary sucrose levels (from any time
spot urine samples) were associated with an increased risk of
being overweight, whereas higher self-reported sugar intake was
associated with a decreased risk (12).
The principle behind this biomarker is based on the
understanding that very small amounts of sucrose can evade
hydrolysis by sucrase and be absorbed in the jejunum as a
disaccharide instead of being cleaved into glucose and fructose
Abbreviations: BMI, body mass index; BP, blood pressure; e-GFR, estimated
glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; LTPA, leisure-time physical activity; MDC-CC, malmö diet and
cancer-cardiovascular cohort; MOS, malmö offspring study; PC, principal
component; QC, quality control; SSB, sugar-sweetened beverage; U-fructose,
urinary fructose; U-osm, urine osmolality; U-sucrose, urinary sucrose; U-sugars,
sum of urinary sucrose and fructose.
(10, 14). Fructose, either directly from the diet or as hydrolyzed
sucrose, is transported to the liver and only small amounts can
evade the hepatic metabolism and remain in the circulation.
In the circulation, sucrose and fructose, unlike glucose, are not
hormonally regulated by insulin, and hence, non-metabolized
sucrose and fructose are excreted in the urine (15). At most,
∼0.05% of consumed sucrose and fructose is excreted in the urine
and detected in 24-h samples, but this small amount correlates
very well with sugar intake under controlled dietary intake and
urination conditions (r = 0.88) (6). This correlation exists even
though the dietary and urinary sugars reflect somewhat different
factors: consumed and absorbed sugars. However, there is a lack
of knowledge on the performance of this biomarker in free living
populations and in overnight urine instead of 24-h urine samples,
which means that both the biomarker and self-reported dietary
data in this study are subject to individual uncertainties.
This biomarker from non-24-h urine samples classifies as a
so-called concentration biomarker, and therefore lacks the ability
to predict true sugar intake and to use for regression calibration
(10, 16). However, Freedman et al. (17, 18) have proposed that
combining self-reported intake with concentration biomarkers
into composite measures is a way to improve investigation of
diet-disease relationships.
The objective of this study was to compare the measurement
of sucrose and fructose in overnight urine samples, self-reported
sugar intake and their combination, as well as to assess and
compare their associations with cardiometabolic risk factors.
MATERIALS AND METHODS
Study Design and Subjects
The Malmö Offspring Study (MOS) is a prospective cohort
comprised of adult children and grandchildren of participants
from theMalmöDiet and Cancer-Cardiovascular Cohort (MDC-
CC), which was conducted in the 1990s. The individuals
comprising MOS were recruited through invitation letters
beginning in 2013. The eligibility criteria were a minimum
of 18 years of age and at least one parent or grandparent
who participated in the MDC-CC. The participants visited the
research clinic twice (∼1 week apart) for clinical examinations,
collection of biological samples and instructions on how to fill
in a lifestyle questionnaire and maintain a 4-day web-based
food record at home (19). Participants started recording their
diet prospectively the day after their first visit and brought
their overnight urine samples on the morning of the second
visit. For the present cross-sectional study, from the first 1,532
urine samples collected in the MOS, we selected those from
all the non-diabetic participants with complete dietary data
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and a reported energy intake within the range of 500–6,000
kcal/d (Figure 1). The MOS received ethical approval from
the Regional Ethics Committee in Lund (Dnr.2012/594) and
all the participants signed a written informed consent form
prior to participation, all in accordance with the Declaration
of Helsinki.
Dietary Data
Dietary data were collected using the Riksmaten2010 method,
developed by the Swedish National Food Agency, which involves
an online 4-day web-based food record (20). Each participant
started recording their diet on the day after the first visit
to the research clinic to ensure representation of all days
of the week among the studied population. The participants
were instructed to record everything they consumed for
four consecutive days. The portion size was estimated using
photographs of different portion sizes, and the food record
was linked to the food database of the Swedish National
Food Agency.
Data on total mono- and disaccharides and sucrose were
obtained from the food database. Total sugars (g/d) were
calculated by summing all mono- and disaccharides (which
includes glucose, fructose, galactose, sucrose, lactose and
maltose), and the total sugar density (g/1,000 kcal) was calculated
by dividing the total sugar intake by the energy intake/1,000. The
level of added sugars, as defined by the European Food Safety
Authority and the Nordic Nutrition Recommendations: “The
term “added sugars” refers to sucrose, fructose, glucose, starch
hydrolysates (glucose syrup, high-fructose syrup) and other
isolated sugar preparations used as such or added during food
preparation and manufacturing.” (21, 22) (including isolated
sugar preparations such as honey and syrup), was estimated
by subtracting naturally occurring monosaccharides and sucrose
in fruits and berries (10 g/100 g), vegetables (3 g/100 g), and
juices (8 g/100 g) from the sum of the reported intake of
monosaccharides and sucrose (assuming that lactose andmaltose
are not added to foods). The following formula was used for
the estimation (all intake variables are expressed in g/day):
added sugar = monosaccharides + sucrose—(fruit and berries
× 0.1 + vegetables × 0.03 + juice × 0.08). The resulting value
was transformed into the percentage of non-alcoholic energy
intake (E%). The total sugar density is expressed in g/1,000
kcal, whereas the added sugar density is expressed in E% to
facilitate comparisons with previous studies. The investigated
sugar sources were desserts (desserts, cakes, cookies, pastries
and ice cream), sweets (sweets, chocolate and bars), toppings
expressed in servings/day (1 serving of table sugar, syrup or
honey = 10 g, 1 serving of jam, marmalade or jelly = 20 g),
sugar-sweetened beverages (SSBs; soft drinks, non-carbonated
sugar-sweetened drinks, chocolate drinks), fruits (fruits and
berries including dried and preserved) and juices (fruit and
vegetable juices). One subject outlier was excluded from the
statistical analysis due to an extremely high reported juice
intake, which resulted in an unreasonable estimation of added
sugar intake; and thus, the total study sample comprised 991
subjects (Figure 1). The added sugar intake (E%) was the dietary
variable primarily investigated in this study because that is what
FIGURE 1 | Flow chart of participants and urine samples in the Malmö
Offspring Study. U-sucrose, urinary sucrose; U-fructose, urinary fructose;
U-sugars, sum of urinary sucrose and fructose.
is of most interest in terms of cardiometabolic risk. This is
despite the fact that the measured urinary biomarker cannot
distinguish between naturally occurring and added sucrose
and fructose, but the alternative, i.e., investigation of the total
sugar intake, does not perfectly reflect the biomarker either
because both lactose and maltose form a substantial part of the
total sugars.
Urinary Data
Collection of Overnight Urine Samples
Comprehensive instructions to ensure a standardized urine
collection procedure were provided on the first visit to the
research clinic. Overnight urine was collected on the morning
of the second research visit. The instructions were to empty the
bladder before bedtime and collect all urine thereafter during
the night and all of the first morning urine in a plastic bottle
while fasting. At the clinic, the urine samples were stored in a
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refrigerator for a maximum of 4 h before being transferred to
the laboratory, where they were aliquoted and relocated to a
−80◦C freezer.
Preparation of Calibration Standards, Internal
Standards and Quality Control
Calibration standards of sucrose and fructose (Sigma Aldrich,
Gillingham, UK) were prepared ranging from 0.1 to 500 µmol/L.
Stable isotope-labeled internal standard solution was prepared
in acetonitrile containing 13C12-sucrose at 4µg/mL and
13C6-
fructose at 10µg/mL. Quality controls (QCs) of 1 µmol/L (low
QC), 7.5 µmol/L (medium QC), and 75 µmol/L (high QC)
were analyzed in duplicate throughout each batch of samples.
The precision and accuracy of the analysis were assessed by
determining the replicates of the low, medium and high QC
samples across all batches of samples.
Liquid Chromatography-Tandem Mass Spectrometry
(LC-MS/MS)
The urine samples were stored at−80◦C until, thawed at 4◦C
and diluted with the internal standard mix. LC-MS/MS analysis
was performed using an Acquity UPLC system (Waters, Milford,
MA, USA), coupled to a Quattro Ultima tandem quadrupole
mass spectrometer (Micromass, Manchester, UK). The mass
spectrometer was operated through electrospray ionization in
positive ion mode using multiple reaction monitoring mode.
In total, 226 samples were not successfully analyzed, and 81
samples were outside the calibration range and were thus
excluded from the analysis. Out of those 81 samples, those
above the calibration range (24 sucrose samples and 7 fructose
samples) were reanalyzed at a 4-fold-higher dilution and a
calibration range extending to 1,000 µmol/L. These re-analyses
were successfully performed and resulted in re-inclusion for the
sucrose samples (with the exception of 4 samples), but not with
fructose (Figure 1).
Adjustment for Urine Dilution
To adjust for urine dilution, the urinary sugars concentrations
were expressed as ratios to the urine osmolality (U-osm,
mOsm/kg H2O), i.e., in units of (µmol·L
−1)/(mOsm·kg−1). U-
osm was selected for dilution adjustment over urinary creatinine
because the latter could be associated with body mass index
(BMI) and could consequently induce a false association between
urinary sugars and BMI. U-osm was measured using an i-
Osmometer basic (Löser, Germany). The osmolality-adjusted
urinary sucrose (U-sucrose) and fructose (U-fructose) were also
added together and investigated as their sum (U-sugars). U-
sugars was correlated (r = 0.95, P < 0.001) with the sum
of urinary sucrose and fructose adjusted for creatinine. The
osmolality-adjusted urinary sugar variables are used throughout
this paper unless stated otherwise.
Data on Cardiometabolic Risk Factors
During the visits to the research clinic, anthropometrics and
blood pressure were measured, and fasting blood samples were
collected by a research nurse. Weight was measured using
either a calibrated balance beam or a digital scale with the
participant wearing light clothing. Height was measured to the
nearest centimeter using a stadiometer. BMI was calculated
as weight (kg)/height (m)2 (19). Waist circumference was
measured between the lowest rib margin and the iliac crest
with the participant in a standing position. Resting blood
pressure (BP) was assessed while lying after 10min rest as
the mean from two measurements. Fasting blood samples
were drawn and plasma was analyzed directly for fasting
glucose using HemoCue Glucose 201+ (HemoCue AB, Sweden)
and within 4 h for total cholesterol, triglycerides and high-
density lipoprotein (HDL) cholesterol using the Cobas system
(Roche Diagnostics, Germany). Low-density lipoprotein (LDL)
cholesterol was calculated using the Friedewald equation.
Data on Confounding Factors
Data on potential confounders were collected via a lifestyle
questionnaire. Leisure-time physical activity (LTPA) was assessed
using a four-level scale ranging from sedentary to regular
activity (≥3 × 30 min/week). Smoking status was categorized as
never smoked, ex-smoker, irregular smoker, and regular smoker.
Alcohol consumption habits were assessed on a five-level scale
from never to ≥4 times/week, and their education level was
categorized as compulsory school, upper secondary school and
university degree. Data onmedication use were also self-reported
via the lifestyle questionnaire. The relative estimated glomerular
filtration rate (e-GFR) was estimated using the revised Lund-
Malmö equation (23).
Misreporting of energy intake was evaluated according
to Goldberg and Black’s cutoffs for misreporting of energy
intake based on a two-standard-deviations discrepancy between
individual physical activity levels and the ratio of energy intake
to the basal metabolic rate (24). Individual physical activity
levels were obtained from the Riksmaten2010 based on physical
activity at work and LTPA (both assessed using a four-level scale
ranging from sedentary to heavy manual labor/exercise ≥3 ×
30 min/week). To enable comparisons with the ratio of energy
intake to basal metabolic rate, basal metabolic rate was calculated
using the Oxford equations by taking sex, age, and weight into
account (22, 25).
Statistical Analysis
All statistical analyses were performed using Stata/SE (version 15;
StataCorp LLC, USA). The urinary sugar variables were skewed
even after adjustment for U-osm and were therefore log10-
transformed. Since sex differences were observed, the statistical
analyses were mainly performed divided by sex.
The baseline characteristics were evaluated separately for men
and women over quintiles of U-sugars and 6 categories of added
sugar intake, namely, ≤5E, >5-≤7.5E, >7.5-≤10E, >10-≤15E,
>15-≤20E, and >20E%, which were previously investigated
in relation to mortality in the Malmö Diet and Cancer Study
(26). Categorical variables were expressed as percentages and
continuous variables were expressed and mean (SD) or median
(IQR), dependent on their distribution.
Partial correlation analysis adjusting for energy intake, age,
sex, and BMI was performed between the different urinary sugar
variables and the reported dietary sugar variables to evaluate the
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agreement between the two measurement methods. An alluvial
plot was created to visualize the agreement between the 6 added
sugar intake categories and the quintiles of U-sugars. To assess
misclassification, equal groups are necessary and for this purpose
sex-specific quartiles were used for crosstabulation of the U-
sugars and reported added sugar intake.
We assume no mediation through the urinary sugar
biomarker in the potential association between sugar intake and
cardiometabolic disease. Therefore, according to reasoning by
Freedman et al. (17) the combination of U-sugars and reported
added sugar intake (E%) into one composite measure of exposure
was obtained using both the principal component (PC) method
and the Howe’s method. In the PCmethod, in the case of only two
variables that are positively correlated (such as in this situation),
the first PC is proportional to the sum of the two variables, each
divided by their own standard deviations. In Howe’s method,
all U-sugar values and added sugar values were ranked, and the
ranks were summed (17).
Linear regression was used to examine the associations of U-
sugars, reported added sugar intake (E%) and their composite
measures with cardiometabolic risk factors. In the regression
models, model 1 was adjusted for age and sex [and total
energy intake for the analyses of added sugar intake (E%) and
the composite measures, i.e., the multivariate nutrient density
model was used for energy adjustment (27)], and model 2
was additionally adjusted for educational level, LTPA, smoking
status, alcohol consumption habits and fiber density (g/1,000
kcal). The regressions with total cholesterol, triglycerides, HDL
and LDL cholesterol were also adjusted for the usage of lipid-
lowering drugs, and the regressions with systolic and diastolic
BP were also adjusted for the usage of antihypertensive drugs.
The interaction with sex was evaluated in all regression analyses.
In sex-specific analyses, interactions with obesity (BMI≥30 or
BMI<30) were evaluated for U-sugars, and interactions with
energy underreporting (yes or no) and obesity were evaluated for
added sugar intake.
To further understand the relationships, an attempt to identify
and map out all potential and measured predictors of U-
sugars was performed through partial correlation analyses for
men and women separately. The multivariate partial correlation
model was determined through stepwise backward linear
regression. All covariates were added simultaneously to the
linear regression model, and the covariate with the highest
P-value was excluded from the model in a stepwise manor
until all covariates were deemed statistically significant. The
investigated variables included added sugar intake; intake of
desserts, sweets, toppings, SSBs, fruit, and berries, and juice;
educational level; smoking status; alcohol consumption habits;
LTPA; BMI; waist circumference; systolic BP; fasting glucose; U-
osm; and e-GFR. We investigated U-sugars unadjusted for U-
osm. Instead, U-osm was included as a covariate. All of these sex-
specific partial correlations and multivariate linear regressions
were adjusted for energy intake and age. A significance level
of α = 0.05 was applied and corrections for multiple testing
were not performed. Therefore, the presented P-values should be
interpreted with caution.
RESULTS
Baseline Characteristics
Among the total study sample of 991 participants with complete
dietary data, we obtained valid measurements within the
calibration range for U-sucrose [median 32.7 µmol/L (12.6–
85.7)] from 889 participants and for U-fructose [median 18.0
µmol/L (7.4–44.0)] from 775 participants (not adjusted for U-
osm). In total, 763 participants presented valid measurements
for both U-sucrose and U-fructose (Figure 1). The mean age
of the cohort was 39 years (range 18–69). As observed in
Tables 1, 2, the lowest mean age was seen in the highest groups
of both added sugar and U-sugars. A higher percentage of
women were seen among the low groups of both added sugar
and U-sugars. Among those reporting high added sugar intake,
we observed lower proportions of energy underreporters, high
consumers of alcohol and individuals with regular LTPA ≥3 ×
30 min/week in both men and women. In those with high U-
sugars, the proportions with a university degree appeared to be
lower. High reported energy intake was observed among those
reporting high added sugar intake, but not in those with high
U-sugars. Higher U-osm was observed in women with higher U-
sugars. Intake of most sugar-rich foods and beverages appears to
increase with increasing U-sugars, while intake of fruit appears
to decrease. Although, a substantial part of zero-consumption
has been reported for some of the sugar-rich foods and beverages
(Table 2).
Correlations Between Urinary and Dietary
Sugars
The alluvial plot in Figure 2 displays the agreement between
the 6 categories of added sugar intake and quintiles of U-
sugars based on the proportion of participants belonging to
each category of the two different variables. In assessment
of misclassification, the percentage of gross misclassification
equaled 8% for women and 7% for men, while 32 and
34%, respectively, of the values were correctly classified
(Supplementary Figure 1).
Sucrose intake (g/d), total sugar intake (g/d), total sugar
density (g/1,000 kcal) and added sugar intake (E%) showed a
higher statistically significant correlation with both U-sucrose
and U-sugars (r≈0.20–0.30, P < 0.01), than with U-fructose
(r≈0.11–0.14, P < 0.03), after adjusting for energy intake, age,
sex and BMI (Table 3). Overall, the correlations were slightly
weaker with total sugar and total sugar density (r = 0.21, P <
0.01 and r= 0.20, P < 0.01 with U-sugars, respectively) than with
reported intake of sucrose and added sugar (both r = 0.24, P <
0.01 with U-sugars), and were weaker for women than for men
e.g., (r = 0.20, P < 0.01 and r = 0.27, P < 0.01 between added
sugar intake and U-sugars, respectively). U-sugars correlated
with intake of desserts, sweets and SSBs, but not with toppings,
juice and fruits. Additionally, among men but not women, SSB
intake correlated with all the different urinary sugars, and U-
fructose was positively correlated with juice intake and negatively
correlated with fruit intake.
Frontiers in Nutrition | www.frontiersin.org 5 May 2020 | Volume 7 | Article 62
Ramne et al. Urinary Sugars vs. Reported Sugar Intake
TABLE 1 | Baseline characteristics of women and men in the Malmö Offspring Study across 6 categories of added sugar intake, E%.
Added sugar intake, E% ≤5E% >5E% to ≤7.5E% >7.5E% to ≤10E% >10E% to ≤15E% >15E% to ≤20E% >20E%
Women (n = 533)
n (% women) 13 (34.2) 50 (53.2) 100 (56.5) 192 (52.3) 119 (58.1) 59 (53.6)
University degree, % 60.0 45.8 50.0 48.1 41.7 49.1
LTPA ≥3 × 30 min/wk, % 46.2 38.0 21.0 35.9 35.3 20.3
Current smokers, % 0.0 14.6 11.0 8.15 13.8 19.6
Alcohol consumed >twice/wk, % 40.0 41.7 47.8 26.1 22.9 8.93
Energy underreporters, % 69.2 36.0 31.0 30.2 20.2 28.8
Age, y 39.3 (15) 45.7 (13) 43.2 (12) 39.7 (13) 37.6 (14) 32.5 (11)
BMI, kg/m2 22.2 (1.8) 24.7 (3.2) 25.2 (5.0) 25.0 (4.9) 24.1 (4.3) 26.1 (6.8)
Energy intake, kcal/d 1348 (402) 1569 (398) 1782 (450) 1833 (486) 1894 (493) 1920 (564)
U-osm, mOsm/kg 556 (325) 535 (218) 563 (233) 578 (231) 597 (229) 675 (255)
Men (n = 458)
n (% men) 25 (65.8) 44 (46.8) 77 (43.5) 175 (47.7) 86 (42.0) 51 (43.4)
University degree, % 26.1 23.1 41.8 41.8 21.1 31.3
LTPA ≥3 × 30 min/wk, % 36.0 34.1 36.4 29.7 22.1 19.6
Current smokers, % 8.33 15.4 7.46 9.87 17.8 12.5
Alcohol consumed >twice/wk, % 25.0 53.9 46.3 39.7 28.8 21.7
Energy underreporters, % 64.0 45.5 46.8 30.3 24.4 25.5
Age, y 39.4 (11) 42.2 (15) 41.1 (13) 38.5 (13) 38.2 (13) 37.7 (13)
BMI, kg/m2 27.2 (4.1) 25.9 (3.3) 26.2 (2.9) 25.9 (4.2) 25.9 (4.3) 26.3 (4.1)
Energy intake, kcal/d 1991 (779) 2014 (532) 2127 (532) 2389 (672) 2440 (664) 2497 (669)
U-osm, mOsm/kg 695 (260) 660 (236) 683 (249) 737 (249) 689 (264) 764 (286)
The categorical variables are expressed as percentages. The continuous variables are expressed as the means (SDs).
LTPA, leisure-time physical activity; BMI, body mass index; U-osm, urine osmolality.
Cardiometabolic Risk Factors
Differences between men and women were observed in the
associations between sugar exposure (both added sugar intake
and U-sugars) and several cardiometabolic risk factors. U-
sugars, but not reported added sugar intake, were positively
associated with systolic BP, diastolic BP and fasting glucose
only in women. However, added sugar intake, but not U-
sugars, was negatively associated with fasting glucose in men.
Additionally, in women, both U-sugars and added sugar intake
associated positively with BMI and waist circumference, whereas
among men, U-sugars were negatively associated with BMI
and waist circumference, and no association was observed
for added sugar intake. Statistically significant interactions
with sex were found for the associations of both U-sugars
and added sugar intake with BMI and waist circumference.
Added sugar intake was negatively associated with HDL
cholesterol in both men and women. No associations were
found with total cholesterol, triglycerides or LDL cholesterol
(Table 4).
The combination of U-sugars and reported added sugars into
a composite measure of sugar exposure using the PC method
revealed statistically significant positive associations with BMI,
waist circumference and systolic BP, and a statistically significant
negative association with HDL cholesterol in women, whereas
none of the cardiometabolic risk factors were associated with
the PC of sugar exposure in men (Table 4). Combining by
Howe’s method (Supplementary Table 1) showed resembling
associations with the same cardiometabolic risk factors as when
using the PC method, but overall yielded lower coefficients and
only the associations with HDL were statistically significant.
Energy underreporting was identified as a statistically
significant effect modifier in the associations between reported
added sugar intake and BMI and waist circumference in women.
These positive associations were attenuated after the removal
of energy underreporters. A statistically significant interaction
between obesity andU-sugars was obtained in the regression with
systolic BP in women: obese individuals exhibited a markedly
stronger positive association than the non-obese individuals
(BMI≥30: β = 3.15, P = 0.03; BMI<30: β = 11.9, P < 0.01;
Supplementary Table 2).
Potential Predictors of Overnight Urinary
Sugars
We used stepwise backward linear regression in an attempt
to identify the major predictors of U-sugars (not adjusted
for U-osm) (Table 5). After taking possible and measured
predictors into account, the main predictors of the various
sugar intake variables were added sugar intake for men
(r = 0.31) and intake of desserts (r = 0.10) and sweets
(r = 0.21) for women. U-osm was found to be a strong
predictor in both women and men (r = 0.41 and r = 0.40,
respectively). Systolic BP and fasting glucose also exhibited
positive associations with U-sugars in women, whereas education
level and waist circumference showed negative associations
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TABLE 2 | Baseline characteristics of women and men in the Malmö Offspring Study across quintiles (Q1–Q5) of U-sugars, (µmol·L−1 )/(mOsm·kg−1 ).
Q1 Q2 Q3 Q4 Q5
U-sugars, mean 0.02 0.05 0.09 0.17 0.43
(range), (µmol·L−1)/(mOsm·kg−1) (0.01–0.04) (0.04–0.07) (0.07–0.12) (0.12–0.26) (0.26–3.85)
Women (n = 412)
n (% women) 75 (49.0) 76 (50.0) 70 (45.8) 96 (62.8) 95 (62.5)
University degree, % 50.7 60.0 44.8 50.0 36.0
LTPA≥3 × 30 min/wk, % 29.3 35.5 31.4 25.0 26.3
Current smokers, % 7.04 8.45 10.5 17.4 13.5
Alcohol consumed >twice/wk, % 29.6 32.4 32.8 39.5 21.4
Energy underreporters, % 32.0 25.0 22.9 25.0 27.4
Age, y 41.1 (14) 42.2 (12) 40.1 (13) 39.8 (13) 36.9 (13)
BMI, kg/m2 24.4 (4.17) 25.2 (4.76) 24.6 (4.18) 24.6 (4.27) 25.5 (5.63)
U-osm, mOsm/kg 540 (236) 568 (229) 636 (250) 592 (239) 653 (244)
Energy intake, kcal/d 1,782 (508) 1,869 (481) 1,840 (443) 1,835 (500) 1,864 (536)
Sucrose, g/d 33.0 (20.3) 38.2 (23.7) 35.7 (19.2) 41.2 (23.9) 45.9 (27.8)
Total sugar, g/d 73.7 (30.4) 83.1 (31.2) 76.2 (30.5) 84.3 (35.2) 90.5 (38.4)
Total sugar density, g/1,000 kcal 41.3 (11.3) 44.6 (12.4) 41.1 (12.8) 45.5 (14.5) 48.3 (14.6)
Added sugar, E% 11.6 (4.98) 12.8 (4.50) 12.1 (4.92) 13.6 (5.85) 15.0 (5.42)
Desserts, g/da 25.3 (10.0, 53.1) 28.1 (10.6, 69.8) 35.4 (21.3, 59.5) 38.1 (11.9, 73.1) 37.5 (12.8, 75.0)
Sweets, g/da 10.0 (0.5, 20.8) 13.4 (3.5, 28.9) 13.8 (3.5, 37.0) 15.5 (4.3, 35.9) 13.8 (0.0, 50.0)
Toppings, servings/da 0.24 (0.0, 0.54) 0.05 (0.0, 0.84) 0.0 (0.0, 0.59) 0.26 (0.0, 0.71) 0.0 (0.0, 0.54)
SSBs, g/da 0.0 (0.0, 50.0) 0.0 (0.0, 75.0) 0.0 (0.0, 125) 25.0 (0.0, 129) 0.0 (0.0, 150)
Juice, g/da 0.0 (0.0, 75.0) 0.0 (0.0, 90.6) 0.0 (0.0 (75.0) 0.0 (0.0, 87.5) 0.0, 0.0, 75.0)
Fruits, g/da 103 (39.0, 170) 95.1 (55.8, 169) 81.1 (47.2, 128) 82.3 (32.6, 152) 75.6 (24.5, 155)
Men (n = 351)
n (% men) 78 (51.0) 76 (50.0) 83 (54.3) 57 (37.3) 57 (37.5)
University degree, % 33.3 50.8 30.0 25.5 22.7
LTPA ≥3 × 30 min/wk, % 32.1 26.3 28.9 28.1 29.8
Current smokers, % 7.04 8.82 18.1 6.38 15.9
Alcohol consumed >twice/wk, % 40.3 48.5 40.9 36.2 27.3
Energy underreporters, % 39.7 36.8 33.7 31.6 21.1
Age, y 39.7 (11.0) 41.5 (12.8) 39.9 (14.5) 39.1 (13.7) 36.9 (14.3)
BMI, kg/m2 27.5 (4.52) 25.9 (3.53) 25.8 (3.61) 26.4 (3.98) 25.5 (4.23)
U-osm, mOsm/kg 740 (264) 698 (262) 692 (245) 689 (260) 781 (230)
Energy intake, kcal/d 2,278 (707) 2,297 (670) 2,370 (624) 2,285 (575) 2,479 (698)
Sucrose, g/d 36.6 (29.3) 47.4 (31.7) 47.0 (25.9) 50.3 (33.7) 66.8 (39.9)
Total sugar, g/d 79.9 (40.6) 93.7 (46.3) 96.7 (41.0) 97.7 (47.4) 113 (49.3)
Total sugar density, g/1,000 kcal 34.2 (12.0) 40.5 (13.6) 40.5 (12.9) 42.0 (16.3) 45.3 (14.5)
Added sugar, E% 10.6 (4.94) 12.5 (5.06) 13.0 (5.06) 13.8 (5.51) 15.4 (6.15)
Desserts, g/da 27.5 (0.0, 57.5) 30.0 (6.3, 63.5) 38.0 (10.0, 72.5) 33.8 (10.0, 72.5) 56.3 (15.0, 94,8)
Sweets, g/da 0.0 (0.0, 20.5) 7.8 (0.0, 20.8) 11.3 (0.0, 26.3) 9.0 (0.0, 35.0) 12.5 (0.0, 49.0)
Toppings, servings/da 0.0 (0.0, 0.39) 0.09 (0.0, 0.67) 0.31 (0.0, 0.89) 0.0 (0.0, 0.80) 0.0 (0.0, 0.76)
SSBs, g/da 0.0 (0.0, 100) 75.0 (0.0, 175) 75.0 (0.0, 200) 125 (0.0, 275) 200 (0.0, 375)
Juice, g/da 0.0 (0.0, 100) 0.0 (0.0, 150) 0.0 (0.0, 100) 0.0 (0.0, 150) 0.0 (0.0, 150)
Fruits, g/da 42.7 (5.7, 84.5) 57.1 (14.5, 103) 42.5 (12.5, 98.0) 31.7 (4.4, 100) 28.0 (2.0, 64.5)
The categorical variables are expressed as percentages. The continuous variables are expressed as the means (SDs) unless stated otherwise.
adata is expressed as median (IQR) due to skewed distribution.
U-sugars, sum of urinary sucrose and fructose; LTPA, leisure-time physical activity; BMI, body mass index; U-osm, urine osmolality, SSB, sugar-sweetened beverage.
with U-sugars in men. When examining osmolality-adjusted
U-sugars instead, excluding U-osm in the multivariate model,
the same predictors remained to a similar extent (data
not shown).
DISCUSSION
We showed statistically significant correlations of r≈0.20–0.30
between reported sugar intakes and overnight urinary sugars
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FIGURE 2 | Alluvial plot demonstrating the agreement based on
crosstabulation of the 6 categories of reported added sugar intake (≤5E,
>5-≤7.5E, >7.5-≤10E, >10-≤15E, >15-≤20E, and >20E%) and quintiles of
U-sugars (Q1–Q5). U-sugars, sum of urinary sucrose and fructose.
after adjusting for age, sex, energy intake, and BMI. The
relatively low coefficients of these correlations and the modest
agreement observed in the alluvial plot may reflect that both
these measures of sugar intake are subject to random variation
and measurement error. However, importantly, such possible
errors are completely unrelated (misreporting and potential
unknown determinants), which therefore indicates a potential
and need for the combination of these two measurements. As
discussed and shown in both data simulations and in real world
examples by Freedman et al. (17, 18), even when the correlation
between reported intakes and the biomarker is not very high,
combination of the twomeasurements is motivated. Hence, these
two measurements could potentially complement each other to
improve the assessment of the associations between added sugar
intake and cardiometabolic risk.
The observed correlation coefficients in this study agree with
the results of a previous study of spot morning urine samples
in children (r = 0.25) (13). This similarity was obtained even
though the collection of urinary and dietary data did not reflect
the exact same days in our study, which was the case in the
previous study. However, the previous study did not reveal large
differences in the comparison of the single 24-h recall from the
day before collection of the morning spot urine samples and
multiple 24-h recalls (13). The correlation coefficients obtained in
our study are also similar to previous findings obtained with the
validated predictive 24-h urinary sugar biomarker in free living
populations; in the Nutrition and Physical Activity Assessment
Study, the correlation with total sugar density from a 4-day food
record was r = 0.21 (8), which is comparable to that found
in our study between total sugar density and U-sugars (r =
0.20). Because we only can compare against self-reported sugar
intake and not true intake, it is not straightforward to compare
these correlations and the observed exact agreement of 32–34%
to warranted limits used in biomarker validation studies [r =
0.5–0.6 and quartile agreement of at least 50% (28, 29)].
In our study, the correlation of reported added sugar intake
with U-fructose was notably weaker than that with U-sucrose
(0.14 and 0.27, respectively), even though only monosaccharides,
in theory, should be absorbed in the jejunum. In addition,
total sugar (g/d) and total sugar density (g/1,000 kcal) were
not as strongly correlated with the urinary sugars as sucrose
intake (g/d) and added sugar intake (E%). Previous studies
have also revealed weaker correlations for intrinsic sugar
(included in total sugars) than for extrinsic sugars (mainly
added sugars) with the urinary sugar biomarker (13, 30). This
effect could be due to the rate of digestion and absorption
of the sugars, which is believed to be lower when the
sugars are naturally occurring in complex foods compared to
simple sugars added to foods (31). Additionally, the relatively
high intakes of sugars from dairy (lactose, included in total
sugars) in the Swedish diet might contribute to some of
these differences.
We observed slightly stronger correlations between dietary
sugars and urinary sugars in men than in women, which is
supported by the findings of previous studies (7, 12). In addition
to biological differences between men and women, another
plausible reason for the sex differences could be that women
generally tend to underreport their dietary intake more than
men (7, 32, 33). However, we do not know the degree of sugar
intake underreporting in our study, and energy misreporting
does not necessarily reflect misreporting of sugar. However, the
percentage of energy underreporters was lower among those
with higher added sugar intake and tended to be lower in
those with higher U-sugars. Furthermore, the high proportion
of zero-reporters of SSB intake among women (57%), might
contribute to why we only can see a statistically significant
correlation between SSB intake and U-sugars in men but not
in women.
No previous studies have evaluated urinary sugar biomarkers
in relation to cardiometabolic risk factors other than
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TABLE 3 | Partial correlations between U-sucrose, U-fructose and U-sugars and different measures and sources of dietary sugars in all, women and men in the Malmö
Offspring Study.
U-sucrose U-fructose U-sugars
n r P-value n r P-value n r P-value
All
Sucrose (g/d) 889 0.27 < 0.01 775 0.13 < 0.01 763 0.24 < 0.01
Total sugar (g/d) 889 0.22 < 0.01 775 0.12 < 0.01 763 0.21 < 0.01
Total sugar density (g/1,000 kcal) 889 0.22 < 0.01 775 0.13 < 0.01 763 0.20 < 0.01
Added sugar (E%) 889 0.27 < 0.01 775 0.14 < 0.01 763 0.24 < 0.01
Desserts (g/d) 889 0.09 < 0.01 775 0.05 0.14 763 0.11 < 0.01
Sweets (g/d) 889 0.20 < 0.01 775 0.07 0.04 763 0.18 < 0.01
Toppings (servings/d) 889 0.03 0.31 775 −0.01 0.78 763 0.02 0.67
SSBs (g/d) 889 0.18 < 0.01 775 0.09 0.01 763 0.16 < 0.01
Juice (g/d) 889 0.04 0.25 775 0.11 < 0.01 763 0.06 0.08
Fruits (g/d) 889 −0.04 0.21 775 −0.04 0.25 763 −0.05 0.15
Women
Sucrose (g/d) 467 0.23 < 0.01 421 0.11 0.03 412 0.19 < 0.01
Total sugar (g/d) 467 0.19 < 0.01 421 0.13 < 0.01 412 0.18 < 0.01
Total sugar density (g/1,000 kcal) 467 0.15 < 0.01 421 0.12 0.02 412 0.16 < 0.01
Added sugar (E%) 467 0.21 < 0.01 421 0.13 < 0.01 412 0.20 < 0.01
Desserts (g/d) 467 0.05 0.25 421 0.005 0.92 412 0.09 0.07
Sweets (g/d) 467 0.21 < 0.01 421 0.12 0.02 412 0.20 < 0.01
Toppings (servings/d) 467 −0.02 0.65 421 −0.05 0.33 412 −0.04 0.48
SSBs (g/d) 467 0.08 0.08 421 0.01 0.79 412 0.05 0.34
Juice (g/d) 467 0.02 0.71 421 0.05 0.27 412 0.03 0.48
Fruits (g/d) 467 −0.05 0.33 421 0.0007 0.99 412 −0.03 0.60
Men
Sucrose (g/d) 422 0.30 < 0.01 354 0.14 < 0.01 351 0.28 < 0.01
Total sugar (g/d) 422 0.25 < 0.01 354 0.11 0.03 351 0.22 < 0.01
Total sugar density (g/1,000 kcal) 422 0.27 < 0.01 354 0.12 0.02 351 0.23 < 0.01
Added sugar (E%) 422 0.31 < 0.01 354 0.13 0.01 351 0.27 < 0.01
Desserts (g/d) 422 0.13 < 0.01 354 0.11 0.05 351 0.12 0.02
Sweets (g/d) 422 0.18 < 0.01 354 0.01 0.83 351 0.16 < 0.01
Toppings (servings/d) 422 0.08 0.12 354 0.02 0.68 351 0.05 0.34
SSBs (g/d) 422 0.26 < 0.01 354 0.16 < 0.01 351 0.25 < 0.01
Juice (g/d) 422 0.05 0.33 354 0.15 < 0.01 351 0.09 0.11
Fruits (g/d) 422 −0.04 0.37 354 −0.12 0.03 351 −0.10 0.05
The partial correlations are adjusted for age, sex, energy intake and BMI (not adjusted for sex in sex-specific analyses). The urinary sugar variables are log10-transformed.
U-sucrose, urinary sucrose; U-fructose, urinary fructose; U-sugars, sum of urinary sucrose and fructose; SSB, Sugar-sweetened beverages; BMI, body mass index.
anthropometric measurements. The examination of spot
urinary sucrose (not morning urine) in relation to obesity
measures in the EPIC Norfolk cohort revealed a positive
association between the risk of being overweight and higher
spot urinary sucrose, whereas a negative association between
risk of being overweight and higher self-reported sugar intake
(12). Hence, it can be speculated that the lack of a positive
association between reported sugar intake and risk of being
overweight might be partly explained by a measurement error
bias in the dietary assessment, which is not an issue with
the objective measurement of sucrose in spot urine samples.
Similar patterns were observed in our study for systolic BP,
diastolic BP and fasting glucose in women; these parameters
were positively associated with U-sugars but not with reported
added sugar intake. However, such a pattern was not observed
for the other cardiometabolic risk factors. In fact, both U-
sugars and added sugar intake were positively associated
with BMI and waist circumference and negatively associated
with HDL cholesterol in women, indicating quite credible
associations, and the combination of the two measurements
strengthened the associations for these cardiometabolic risk
factors. In men, however, U-sugars were negatively associated
with BMI and waist circumference, while no association was
found with added sugar intake. Nevertheless, cross-sectional
examination of BMI and waist circumference in relation to
dietary intake is difficult because large body measurements
might affect one’s dietary awareness more than the “nonvisual”
cardiometabolic risk factors. Hence, the direction of the
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TABLE 4 | Linear regression of U-sugars, added sugar intake and their composite measure (PC) on cardiometabolic risk factors in the Malmö Offspring Study.
All Women Men
n ß 95% CI P-int sex n ß 95% CI n ß 95% CI
BMI (kg/m2)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 763 0.15 −0.45, 0.77 412 1.03 0.14, 1.92 351 −1.00 −1.84, −0.16
Model 2 677 0.08 −0.58, 0.74 <0.01 381 1.05 0.12, 1.97 296 −1.45 −2.40, −0.51
Added sugar (E%)
Model 1 991 0.08 0.02, 0.13 533 0.14 0.06, 0.22 458 0.01 −0.05, 0.08
Model 2 889 0.03 −0.03, 0.09 0.03 493 0.10 0.01, 0.19 396 −0.03 −0.10, 0.05
Composite measure
Model 1 763 0.35 0.15, 0.55 412 0.55 0.28, 0.82 351 −0.04 −0.35, 0.27
Model 2 677 0.26 0.04, 0.48 <0.01 381 0.50 0.22, 0.79 296 −0.24 −0.59, 0.11
Waist circumference (cm)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 763 −0.09 −1.68, 1.50 412 2.00 −0.21, 4.21 351 −2.94 −5.18, −0.70
Model 2 677 −0.20 −1.84, 1.45 <0.01 381 2.02 −0.23, 4.28 296 −3.79 −6.19, −1.39
Added sugar (E%)
Model 1 991 0.24 0.11, 0.37 533 0.34 0.14, 0.53 458 0.13 −0.05, 0.30
Model 2 889 0.15 0.01, 0.29 0.05 493 0.25 0.03, 0.46 396 0.05 −0.14, 0.24
Composite measure
Model 1 763 1.00 0.49, 1.51 412 1.34 0.68, 2.00 351 0.23 −0.60, 1.06
Model 2 677 0.76 0.22, 1.30 <0.01 381 1.19 0.51, 1.88 296 0.19 −1.09, 0.70
Total cholesterol (mmol/L)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 763 −0.08 −0.22, 0.05 412 −0.06 −0.23, 0.11 351 −0.11 −0.33, 0.11
Model 2 677 −0.14 −0.28, 0.01 0.91 381 −0.12 −0.30, 0.06 296 −0.15 −0.40, 0.10
Added sugar (E%)
Model 1 990 −0.006 −0.02, 0.01 532 −0.009 −0.02, 0.01 458 −0.002 −0.02, 0.02
Model 2 888 −0.009 −0.02, 0.004 0.41 492 −0.02 −0.03, 0.0003 396 −0.001 −0.02, 0.02
Composite measure
Model 1 763 −0.02 −0.06, 0.03 412 −0.02 −0.07, 0.04 351 −0.01 −0.09, 0.07
Model 2 677 −0.03 −0.07, 0.02 0.69 381 −0.03 −0.08, 0.03 296 −0.02 −0.11, 0.08
Triglycerides (mmol/L)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 757 0.04 −0.05, 0.13 409 0.02 −0.07, 0.11 348 0.06 −0.11, 0.23
Model 2 671 0.02 −0.08, 0.11 0.96 378 0.007 −0.09, 0.11 293 −0.01 −0.20, 0.18
Added sugar (E%)
Model 1 980 0.007 −0.001, 0.01 527 −0.00001 −0.01, 0.01 453 0.01 −0.001, 0.02
Model 2 878 0.003 −0.01, 0.01 0.49 487 −0.004 −0.01, 0.01 391 0.006 −0.01, 0.02
Composite measure
Model 1 757 0.03 −0.00001, 0.06 409 0.01 −0.02, 0.04 348 0.06 −0.01, 0.12
Model 2 671 0.02 −0.01, 0.05 0.49 378 0.003 −0.03, 0.03 293 0.03 −0.03, 0.10
HDL cholesterol (mmol/L)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 763 −0.06 −0.13, −0.003 412 −0.10 −0.19, −0.01 351 −0.02 −0.10, 0.06
Model 2 677 −0.04 −0.11, 0.02 0.16 381 −0.07 −0.17, 0.02 296 0.01 −0.07, 0.09
Added sugar (E%)
Model 1 990 −0.02 −0.02, −0.01 532 −0.02 −0.03, −0.01 458 −0.01 −0.02, −0.005
Model 2 888 −0.01 −0.02, −0.01 0.04 492 −0.02 −0.02, −0.01 396 −0.009 −0.02, −0.002
Composite measure
Model 1 763 −0.04 −0.06, −0.02 412 −0.05 −0.08, −0.02 351 −0.03 −0.06, −0.01
Model 2 677 −0.03 −0.05, −0.01 0.32 381 −0.03 −0.06, −0.001 296 −0.03 −0.06, 0.002
(Continued)
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TABLE 4 | Continued
All Women Men
n ß 95% CI P-int sex n ß 95% CI n ß 95% CI
LDL cholesterol (mmol/L)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 763 −0.06 −0.18, 0.06 412 −0.02 −0.17, 0.13 351 −0.11 −0.31, 0.09
Model 2 677 −0.13 −0.26, 0.01 0.66 381 −0.09 −0.26, 0.07 296 −0.16 −0.39, 0.07
Added sugar (E%)
Model 1 989 0.006 −0.004, 0.02 531 0.006 −0.01, 0.02 458 0.007 −0.01, 0.02
Model 2 887 0.002 −0.01, 0.01 0.68 491 −0.003 −0.02, 0.01 396 0.008 −0.01, 0.03
Composite measure
Model 1 763 0.01 −0.03, 0.05 412 0.02 −0.03, 0.06 351 0.006 −0.07, 0.08
Model 2 677 −0.006 −0.05, 0.04 0.90 381 −0.006 −0.06, 0.04 296 0.008 −0.07, 0.09
Systolic BP (mmHg)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 761 2.92 1.13, −4.70 410 4.22 1.74, 6.71 351 1.54 −0.98, 4.05
Model 2 675 2.95 0.99, 4.92 0.22 379 4.63 1.96, 7.30 296 1.30 −1.55, 4.16
Added sugar (E%)
Model 1 988 −0.09 −0.24, 0.05 530 −0.02 −0.23, 0.20 458 −0.12 −0.31, 0.07
Model 2 886 −0.09 −0.26, 0.08 0.87 490 −0.02 −0.27, 0.22 396 −0.09 −0.31, 0.13
Composite measure
Model 1 761 0.48 −0.11, 1.06 410 0.89 0.13, 1.66 351 0.13 −0.79, 1.06
Model 2 675 0.46 −0.19, 1.12 0.55 379 1.01 0.17, 1.85 296 −0.09 −1.13, 0.96
Diastolic BP (mmHg)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 761 1.10 −0.13, 2.33 410 1.80 0.16, 3.43 351 0.17 −1.71, 2.04
Model 2 675 1.30 −0.01, 2.62 0.43 379 1.81 0.07, 3.55 296 0.58 −1.48, 2.64
Added sugar (E%)
Model 1 988 0.03 −0.07, 0.13 530 0.008 −0.13, 0.15 458 0.05 −0.09, 0.20
Model 2 886 −0.01 −0.12, 0.10 0.98 490 −0.02 −0.18, 0.14 396 0.003 −0.15, 0.16
Composite measure
Model 1 761 0.54 0.14, 0.94 410 0.49 −0.01, 0.99 351 0.60 −0.08, 1.28
Model 2 675 0.45 0.02, 0.88 0.86 379 0.48 −0.06, 1.02 296 0.41 −0.34, 1.16
Fasting glucose (mmol/L)
U-sugars (µmol·L−1 )/(mOsm·kg−1 )
Model 1 762 0.09 −0.003, 0.19 412 0.14 0.04, 0.25 350 0.01 −0.15, 0.18
Model 2 677 0.10 0.0003, 0.20 0.22 381 0.16 0.05, 0.26 296 0.03 −0.17, 0.22
Added sugar (E%)
Model 1 990 −0.007 −0.01, 0.001 533 −0.003 −0.01, 0.01 457 −0.01 −0.02, −0.00001
Model 2 889 −0.008 −0.02, 0.001 0.04 493 −0.002 −0.01, 0.01 396 −0.01 −0.03, 0.001
Composite measure
Model 1 762 −0.0003 −0.03, 0.03 412 0.009 −0.02, 0.04 350 −0.03 −0.09, 0.03
Model 2 677 −0.0004 −0.03, 0.03 0.11 381 0.01 −0.02, 0.05 296 −0.03 −0.10, 0.04
Total cholesterol, triglycerides, HDL, and LDL cholesterol and fasting glucose are measured in plasma. U-sugars are log10-transformed. The composite measure is the first PC of the
two variables U-sugars and added sugars.
Model 1 is adjusted for age and sex (and energy intake for added sugar and the composite measure).
Model 2 is additionally adjusted for educational level, LTPA, smoking status, alcohol habits, and fiber density. Regressions with total cholesterol, triglycerides, HDL, and LDL cholesterol
are additionally adjusted for usage of lipid lowering drugs and regressions with systolic and diastolic BP are additionally adjusted for usage of antihypertensive drugs.
U-sugars, sum of urinary sucrose and fructose; PC, principal component; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; BP, blood pressure; LTPA,
leisure-time physical activity.
observed associations is uncertain. Furthermore, there may
exist sex differences in the effects on weight gain from a high
sugar diet as it has been observed that the inhibition of lipolysis
by insulin is more profound in women than men (34). Our
observed sex differences in the associations with cardiometabolic
risk factors were unexpected findings outside the scope of
our study objective, which futures studies are encouraged
to elucidate.
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TABLE 5 | Partial correlation coefficients between U-sugars (not adjusted for U-osm) and its potential predictors in women and men of the Malmö Offspring Study.
Women (n = 373) Men (n = 295)
Separate modelsa Multivariate modela, b Separate modelsa Multivariate modela, b
r P r P r P r P
Added sugar (E%) 0.23 < 0.01 0.27 < 0.01 0.31 < 0.01
Desserts (g/d) 0.09 0.08 0.10 0.04 0.14 < 0.01
Sweets (g/d) 0.22 < 0.01 0.21 < 0.01 0.16 < 0.01
Toppings (servings/d) −0.02 0.72 0.05 0.35
SSBs (g/d) 0.07 0.15 0.25 < 0.01
Fruits (g/d) −0.10 0.05 −0.14 0.01
Juice (g/d) 0.02 0.68 0.10 0.07
Education level −0.12 0.03 −0.12 0.05 −0.13 0.02
Smoking status 0.05 0.35 0.06 0.28
Alcohol habits −0.09 0.09 −0.005 0.93
LTPA −0.05 0.34 −0.03 0.56
BMI (kg/m2 ) 0.11 0.02 −0.08 0.12
Waist circumference (cm) 0.09 0.08 −0.08 0.12 −0.18 < 0.01
Systolic BP (mmHg) 0.18 < 0.01 0.17 < 0.01 0.08 0.13
Fasting glucose (mmol/L) 0.13 < 0.01 0.12 0.01 0.01 0.78
U-osm (mOsm/kg) 0.41 < 0.01 0.41 < 0.01 0.39 < 0.01 0.40 < 0.01
e-GFR (ml/min/1.73 m2) −0.05 0.33 −0.08 0.16
aAll partial correlations are adjusted for age and energy intake.
bThe multivariate partial correlation model was determined through stepwise backward linear regression. All covariates were added simultaneously to a linear regression model and the
covariate with the highest P-value was excluded in a stepwise manner from the model until all covariates were deemed significant.
U-sugars are log10-transformed. Fasting glucose is measured in plasma.
U-sugars, sum of urinary sucrose and fructose; U-osm, urine osmolality; SSB, sugar-sweetened beverages; LTPA, leisure-time physical activity; BMI, body mass index; BP, blood
pressure; e-GFR, estimated glomerular filtration rate.
Previous studies have discussed whether the amount of
urinary sucrose and fructose might differ between obese and
lean participants (11, 35) due to the potentially higher gut
permeability of obese individuals (36, 37). Therefore, the
associations between U-sugars and measures of obesity might be
due to other underlying causes in addition to the notion that a
high sugar intake would lead to weight gain. Nevertheless, no
difference in the 24-h urinary levels of either sucrose or fructose
in obese compared with normal weight subjects was observed in a
randomized controlled trial (35). In women, we observed positive
correlations between U-sugar and systolic BP and fasting glucose
and these parameters also fell out as predictors of U-sugars,
but one could discuss the putative causal direction of these
associations. In addition to the theory that a high sugar intake
would lead to an impaired metabolic status, both systolic BP and
fasting glucose are major risk factors for renal insufficiency and
it is possible that this could influence urinary excretion of sugars
(38). However, to our knowledge, no previous study has shown
that the amounts of sucrose and fructose excreted in the urine is
affected by insulin resistance. Because only glucose is regulated
by insulin in the circulation, the same principle as for urinary
excretion of glucose cannot be applied to sucrose and fructose.
The limitations of this study are the lack of longitudinal
data for the cardiometabolic risk factors and that urinary
sugar data is generated from overnight urine samples instead
of 24-h samples. We were therefore also bound to use
other methods than regression calibration for combining the
biomarker with reported intake (10). To date, the overnight
urine biomarker has only been compared to self-reported
sugar intake data, which cannot be used for validating a
nutritional biomarker (39), and no earlier study has ever
reported the correlation between the sugar concentrations in
overnight urine samples and 24-h urine samples. However,
the benefit of using overnight samples over any time spot
samples is that they are less affected by recent past meals (40).
Furthermore, residual confounding can almost be considered
indisputable, and future studies are needed to identify the
determinants of spot and overnight urinary sugars. Therefore,
the following important question remains: Which measurement
is most valid, the self-reported added sugar intake, which is
likely to be biased by misreporting, or the sum of sucrose
and fructose in overnight urine samples, which only reflects
a point measurement and for which determinants other
than sugar intake remain unknown? At this current state of
knowledge, we believe that they both contribute partly to
the truth and may complement each other. However, this
must be validated against true sugar intake or the 24-h
urinary sucrose and fructose biomarker in the future. Future
studies should also investigate potential sex differences to
improve the understanding of the urinary sugar biomarker,
as well as considering the use of repeated overnight or
spot urine samples to obtain improved precision, while
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still facilitating urine collection as compared with 24-h
urine sampling.
In summary, we found statistically significant correlations
at levels of r≈0.20–0.30 and demonstrated the potential for
using the sugar level in overnight urine samples to complement
self-reported dietary data in investigations of cardiometabolic
risk. The combination of U-sugars and added sugar intake
indicated that a higher sugar intake in women is associated with
higher BMI, waist circumference and systolic BP and lower HDL
cholesterol. Considering the potential gains from collecting only
overnight urine instead of 24-h urine in regard to participant
burden, drop-out rates, missing data and selective participation,
the overnight urinary sugar biomarker calls for further validation.
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